This company seems to have been delisted
Reason: Merged with Cytocom
Source: https://www.biospace.com/article/releases/cytocom-and-cleveland-biolabs-announce-definitive-merger-agreement/
Reason: Merged with Cytocom
Source: https://www.biospace.com/article/releases/cytocom-and-cleveland-biolabs-announce-definitive-merger-agreement/
Cleveland BioLabs
CBLI
C$4.35
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Cleveland BioLabs (CBLI)
Revenue in 2020 (TTM): C$0.84 Million
According to Cleveland BioLabs 's latest financial reports the company's current revenue is C$0.86 Million. In 2019 the company made a revenue of C$1.52 Million a decrease over the revenue in the year 2018 that were of C$1.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cleveland BioLabs from 2004 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | C$0.84 M | -44.55% |
| 2019 | C$1.52 M | -2.18% |
| 2018 | C$1.56 M | -41.58% |
| 2017 | C$2.67 M | -44.62% |
| 2016 | C$4.83 M | 29.92% |
| 2015 | C$3.71 M | -26.84% |
| 2014 | C$5.08 M | -56.39% |
| 2013 | C$11.65 M | 137.71% |
| 2012 | C$4.9 M | -59.38% |
| 2011 | C$12.07 M | -42.67% |
| 2010 | C$21.05 M | 6.87% |
| 2009 | C$19.7 M | 204.87% |
| 2008 | C$6.46 M | 133.12% |
| 2007 | C$2.77 M | 18.17% |
| 2006 | C$2.34 M | 50% |
| 2005 | C$1.56 M | 78.97% |
| 2004 | C$0.87 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | C$0.31 M | -64.23% | 🇺🇸 USA |
 OPKO Health
OPK | C$0.94 B | 109,010.82% | 🇺🇸 USA |
 Amgen AMGN | C$46.86 B | 5,400,933.80% | 🇺🇸 USA |
 Novartis NVS | C$73.08 B | 8,423,208.36% | 🇨🇭 Switzerland |
 Bristol-Myers Squibb BMY | C$65.41 B | 7,539,126.58% | 🇺🇸 USA |
 Sanofi SNY | C$65.13 B | 7,507,008.07% | 🇫🇷 France |
 GlaxoSmithKline GSK | C$55.76 B | 6,426,893.17% | 🇬🇧 UK |
 Soligenix SNGX | N/A | N/A | 🇺🇸 USA |
 Eli Lilly LLY | C$67.29 B | 7,755,509.79% | 🇺🇸 USA |